David Roman's Stock Ratings

Goldman Sachs Analyst

David Roman is an analyst at Goldman Sachs. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/12/2024

Overall Average Return

4.94%

Smart Score

58.9%

Overall Average Return Percentile

48th

Number of Ratings

12
Buy NowGet Alert
07/10/2024SOLVBuy Now
Solventum
$48.22-0.46%$54 → $48MaintainsSellGet Alert
05/30/2024BSXBuy Now
Boston Scientific
$78.0315.34% → $90Initiates → BuyGet Alert
05/30/2024EWBuy Now
Edwards Lifesciences
$90.0018.89% → $107Initiates → BuyGet Alert
05/30/2024SYKBuy Now
Stryker
$329.0013.07% → $372Initiates → NeutralGet Alert
05/30/2024ISRGBuy Now
Intuitive Surgical
$438.0014.16% → $500Initiates → BuyGet Alert
05/30/2024ABTBuy Now
Abbott Laboratories
$102.9617.52% → $121Initiates → BuyGet Alert
05/30/2024BDXBuy Now
Becton Dickinson
$226.0821.2% → $274Initiates → BuyGet Alert
05/30/2024BAXBuy Now
Baxter Intl
$33.956.04% → $36Initiates → NeutralGet Alert
05/30/2024SOLVBuy Now
Solventum
$48.2211.99% → $54Initiates → SellGet Alert
05/30/2024ZBHBuy Now
Zimmer Biomet Holdings
$106.5321.09% → $129Initiates → NeutralGet Alert
05/30/2024MDTBuy Now
Medtronic
$77.507.1% → $83Initiates → SellGet Alert
05/30/2024GEHCBuy Now
GE HealthCare Techs
$80.028.72% → $87Initiates → NeutralGet Alert